BackApex Biotechnology Overview

Apex Biotechnology Goodwill

Latest goodwill for 1733.TW: $0.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

Apex Biotechnology Goodwill History

Loading

Apex Biotechnology vs. peers: Goodwill Comparison

Loading

Apex Biotechnology Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Apex Biotechnology (1733.TW) FAQ

As of the most recent data (June 2026), 1733.TW shows a goodwill of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 1733.TW's goodwill is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Apex Biotechnology is outperforming or lagging.

Tracking 1733.TW's goodwill over time shows whether Apex Biotechnology is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Apex Biotechnology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $0) with ownership activity and broader fundamentals.

Apex Biotechnology's goodwill is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.